Home > News > Nanobiotechnology Under Pressure to Justify Funding it has Received
August 30th, 2005
Nanobiotechnology Under Pressure to Justify Funding it has Received
Abstract:
Nanotechnology has received as much media attention (as) any other science sector since the space race of the 1960s. This hype has attracted large sums of 'reactionary' public and venture capital funding, and has brought in its wake tremendous pressure on market participants to deliver results.
The onus is now on participants in the nanobiotechnology applications sector to incorporate extensively researched technologies into commercially viable products.
Source:
prnewswire
Bookmark:
Investments/IPO's/Splits
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013
Nanomedicine
Nanoparticle Delivers Large Protein Complex to Cancer Cell Nucleus May 20th, 2013
Protein 'Passport' Helps Nanoparticles Get Past Immune System May 20th, 2013
Nanoparticle Harnesses Powerful Radiation Therapy for Cancer May 20th, 2013
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Announcements
JPK reports on single molecule research at IISER Pune in India using AFM and CellHesion techniques May 21st, 2013
Imec and GLOBALFOUNDRIES collaborate to advance high-density memory technology: STT-MRAM offers enhanced performance and scalability for embedded and standalone applications May 21st, 2013
International survey supports need for built-in water protection on smartphones and tablets May 21st, 2013
Rice unveils method for tailoring optical processors: Arranging nanoparticles in geometric patterns allows for control of light with light May 21st, 2013